Evidence map›Paper›PMID 30681295›Full record

ArticleCPT: pharmacometrics & systems pharmacology2019

Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America.

Manuel Ibarra, Teresa Dalla Costa, Paula Schaiquevich, Rodrigo Cristofoletti, Ignacio Hernández González, Nicte S Fajardo-Robledo, Marcela Aragón Novoa, Marisín Pecchio, Ignacio Cortinez, Iñaki F Trocóniz and 1 more

Abstract readConference Proceedings
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Advancing drug development with "Fit-for-Purpose" modeling informed approaches.Journal of pharmacokinetics and pharmacodynamics · 2025
    Review
  2. Article
  3. What "Impact" Do NLME Publications Have Outside Our Community?CPT: pharmacometrics & systems pharmacology · 2020
    Article
  4. CPT: Pharmacometrics & Systems Pharmacology 2.0.CPT: pharmacometrics & systems pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Manuel IbarraPharmaceutical Sciences Department, Faculty of Chemistry, Bioavailability and Bioequivalence Centre for Medicine Evaluation, Universidad de la República, Montevideo, Uruguay.
Teresa Dalla CostaPharmacokinetics and PK/PD Modeling Laboratory, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Paula SchaiquevichNational Scientific and Technical Research Council, Buenos Aires, Argentina.
Rodrigo CristofolettiDivision of Therapeutic Equivalence, Brazilian Health Surveillance Agency, Brasilia, Brazil.
Ignacio Hernández GonzálezDevelopment Department, Isotopes Centre, Mayabeque, Cuba.
Nicte S Fajardo-RobledoPharmacobiology Department, University Center of Exact Sciences and Engineering, University of Guadalajara, Guadalajara, Mexico.
Marcela Aragón NovoaDepartamento de Farmacia, Universidad Nacional de Colombia, Bogotá, Colombia.
Marisín PecchioInstituto de Investigaciones Científicas y Servicios de Alta Tecnología,, Panamá, República de Panamá.
Ignacio CortinezDepartment of Anaesthesiology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Iñaki F TrocónizPharmacometrics and Systems Pharmacology, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
Elba M Romero-TejedaPharmacobiology Department, University Center of Exact Sciences and Engineering, University of Guadalajara, Guadalajara, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug DevelopmentLatin AmericaLegislation, DrugMexicoModels, EconomicPharmacologySpainTranslational Research, Biomedical

Identifiers

PMID30681295
PMCPMC6482274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.